Cargando…

523. Dual vs. Triple Antibiotic Therapy for Carbapenem-Resistant Acinetobacter baumannii Infections

BACKGROUND: Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) remain some of the most difficult to treat due to extremely high rates of resistance. The purpose of this study was to compare the efficacy of dual vs. triple targeted antibiotic regimens for CRAB infections. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Markelwith, Justin Patrick, Vyas, Nikunj M, Condoluci, Mark, Kim, Sungwook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810578/ http://dx.doi.org/10.1093/ofid/ofz360.592

Ejemplares similares

2759. Cefiderocol vs Best Available Therapy for the Treatment of Carbapenem- Resistant Acinetobacter baumannii
por: Daisey, Gabrielle N, et al.
Publicado: (2023)

548. Carbapenem-Resistant Acinetobacter baumannii Antibiotic Susceptibility Testing and Antibiogram Formation, Connecticut 2017–2019
por: Paranandi, Anu, et al.
Publicado: (2019)

202. Implementation and Three-Year Results of Antimicrobial Stewardship Program in a Three Hospital Community Health System
por: Vyas, Nikunj, et al.
Publicado: (2018)

597. False Positive Carbapenemase Test in Carbapenem Resistant Acinetobacter baumannii
por: Tao, Lili, et al.
Publicado: (2023)

636. Genome Epidemiology of Carbapenem-Resistant Acinetobacter baumannii (CRAb) in the United States
por: Iovleva, Alina, et al.
Publicado: (2019)

2158. An outbreak of carbapenem-resistant Acinetobacter baumannii at a tertiary hospital in Ethiopia
por: Adbaru, Mulatu G, et al.
Publicado: (2023)

1447. Cluster of Carbapenem-resistant Acinetobacter baumannii in the Context of Local Community Transmission
por: Darwish, Malik, et al.
Publicado: (2023)

2477. Characteristics of patients infected with Carbapenem-resistant Acinetobacter baumannii complex and Carbapenem-resistant Enterobacterales in Tennessee, 2016–2021
por: Patel, Dipen, et al.
Publicado: (2023)

1855. Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
por: Lee, Chan Mi, et al.
Publicado: (2022)

2557. Development of Rabbit Models of Ventilator-Associated Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Petraitis, Vidmantas, et al.
Publicado: (2023)

551. Burden of Illness in Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals (2014 to 2018)
por: Pogue, Jason M, et al.
Publicado: (2019)

2137. Real World Experience with Eravacycline for the Treatment of Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
por: Lim, Andy, et al.
Publicado: (2023)

1490. Serious Infections Caused by Carbapenem Susceptible and Carbapenem Resistant Acinetobacter baumannii-calcoaceticus Complex - A Retrospective Review
por: Rana, Khurram, et al.
Publicado: (2020)

135. Clinical and Microbiologic Analysis of Risk Factors for Mortality in Patients with Carbapenem-Resistant Acinetobacter baumannii Bacteremia
por: Cho, Eunbeen, et al.
Publicado: (2019)

Quantitative proteomics to study carbapenem resistance in Acinetobacter baumannii
por: Tiwari, Vishvanath, et al.
Publicado: (2014)

Carbapenem-resistant Acinetobacter baumannii outbreak at university hospital
por: Takagi, E.H., et al.
Publicado: (2009)

Fanny pack transmission of carbapenem-resistant Acinetobacter baumannii
por: DelleFave, Amber, et al.
Publicado: (2023)

261 Comparative in vitro Activity of Sitafloxacin and Other Antibiotics Against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii and Carbapenem-Resistant Pseudomonas aeruginosa by Disk Diffusion Method
por: Linasmita, Patcharasarn, et al.
Publicado: (2014)

581. The Epidemiology of Imipenem-Resistant Acinetobacter baumannii Bacteremia in a Pediatric Intensive Care Unit and Carbapenem Use
por: Kim, Dongsub, et al.
Publicado: (2019)

1111. Lack of Effectiveness of Colistin in Carbapenem-Resistant Acinetobacter baumannii : A Retrospective Single Center Cohort Study
por: Kim, Si-Ho, et al.
Publicado: (2023)

Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis
por: Yang, Ya-Sung, et al.
Publicado: (2013)

Optimization of Pyrazole Compounds as Antibiotic Adjuvants Active against Colistin- and Carbapenem-Resistant Acinetobacter baumannii
por: Sannio, Filomena, et al.
Publicado: (2022)

554. Association of emr and mdt Genes in Carbapenem Resistant Acinetobacter baumannii with Clinical Outcome in A Tertiary Care Hospital
por: CHAUDHARY, M O N I K A, et al.
Publicado: (2023)

Mobile genetic elements related to carbapenem resistance in Acinetobacter baumannii
por: Pagano, Mariana, et al.
Publicado: (2016)

Heterocyclic Diaryliodonium-Based Inhibitors of Carbapenem-Resistant Acinetobacter baumannii
por: Kumari, Pooja, et al.
Publicado: (2023)

1990. A Strategy of Mandatory Infectious Disease Consultations on Hospital-acquired Clostridium difficile Infection and Antimicrobial Utilization
por: Hou, Cindy, et al.
Publicado: (2019)

Colistin and Carbapenem-Resistant Acinetobacter baumannii Aci46 in Thailand: Genome Analysis and Antibiotic Resistance Profiling
por: Thadtapong, Nalumon, et al.
Publicado: (2021)

2171. Minocycline Susceptibility in Carbapenem-Resistant Acinetobacter baumannii Blood Isolates in South Korea: Role of tetB Gene in Resistance
por: Kim, Taeeun, et al.
Publicado: (2023)

Acinetobacter baumannii Antibiotic Resistance Mechanisms
por: Kyriakidis, Ioannis, et al.
Publicado: (2021)

813. The Reduction of the acquisition rate of carbapenem resistant Acinetobacter baumannii after room privatization in the intensive care unit
por: Jung, Jongtak, et al.
Publicado: (2020)

842. Impact of Active Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in US Hospitals Between 2014 and 2019
por: Pogue, Jason M, et al.
Publicado: (2020)

Detection and homology analysis of carbapenem resistant Acinetobacter baumannii resistance gene
por: Huang, Hua-Liang, et al.
Publicado: (2023)

Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem–Resistant Acinetobacter baumannii
por: Nwabor, Ozioma F., et al.
Publicado: (2021)

2461. Community-Acquired in Name Only: A Cluster of Carbapenem-Resistant Acinetobacter baumannii in a Burn Intensive Care Unit
por: Shenoy, Erica S, et al.
Publicado: (2019)

O047: The effect of active surveillance culture of carbapenem resistant Acinetobacter baumannii on the occurrence of carbapenem resistant Acinetobacter baumannii bacteremia in a single intensive care unit
por: Kim, G, et al.
Publicado: (2013)

135. Comparing the Bioinformatic and Experimental Approaches for Identifying Antibiotic Resistance Genes on Plasmids of Acinetobacter baumannii
por: Hwang, Munok, et al.
Publicado: (2022)

Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia
por: Shi, HyeJin, et al.
Publicado: (2019)

Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan
por: Chen, C.-H., et al.
Publicado: (2015)

Analysis of penicillin-binding proteins (PBPs) in carbapenem resistant Acinetobacter baumannii
por: Vashist, Jitendra, et al.
Publicado: (2011)

Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid
por: Nigro, Steven J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p2ca81lhr29rgiuknsgj2u70qc